期刊文献+

血清胃蛋白酶原Ⅰ/Ⅱ检测对胃癌诊断及预后判断的意义 被引量:6

Significance of serum pepsinogenⅠ/Ⅱ detection in diagnosis and prognosis of gastric cancer
下载PDF
导出
摘要 目的探讨血清胃蛋白酶原Ⅰ/Ⅱ测定对胃癌诊断及预后判断的意义。方法用酶联免疫吸附实验分别测定胃溃疡、胃癌患者及健康人胃蛋白酶原Ⅰ/Ⅱ含量,并与单抗7相关抗原进行比较。结果健康人血清胃蛋白酶原Ⅰ/Ⅱ浓度分别为(98.77±31.24)ng/mL、(38.68±13.20)ng/mL;胃溃疡患者血清胃蛋白酶原Ⅰ浓度为(250.08±71.29)ng/mL,明显高于健康人(P<0.05),胃蛋白酶原Ⅱ浓度为(31.23±6.83)ng/mL,与健康人比较差异无统计学意义(P>0.05);胃癌患者血清胃蛋白酶原Ⅰ/Ⅱ浓度分别为(31.09±10.24)ng/mL、(9.67±7.23)ng/mL,均明显低于健康人(P<0.05);胃癌术后3年以上无复发或转移者血清胃蛋白酶原Ⅰ/Ⅱ浓度分别为(129.43±51.00)ng/mL、(23.83±13.68)ng/mL,明显高于新诊断胃癌患者(P<0.05);胃溃疡、胃癌患者血清单抗7相关抗原水平离散系数均较大,与胃蛋白酶原Ⅰ水平无相关性,两者在胃癌诊断中的特异性和灵敏度分别为81.1%、56.7%及91.9%、76.7%。结论血清胃蛋白酶原水平的测定可以为胃癌的诊断、疗效观察及预后判断提供依据,并优于血清单抗7相关抗原测定。 Objective To explore the significance of serum pepsinogen(PG) Ⅰ/Ⅱ detection for the diagnosis and prognosis of gastric cancer.Methods ELISA was employed to measure the serum concentration of PG Ⅰ/Ⅱin the patients with gastrelcosis and gastric cancer and healthy people and the results were compared with monoclonal gastric cancer 7 antigen(MG-7Ag).Results In healthy people,the serum concentration of PGⅠ/Ⅱ was(98.77±31.24)ng/mL and(38.68±13.20)ng/mL respectively.In gastrelcosis patients,the concentration of PGⅠ was(250.08±71.29)ng/mL and significantly higher than that in healthy people(P0.05),but the PGⅡ concentration was(31.23±6.83)ng/mL with no statistical difference compared with the healthy people(P0.05).The serum concentrations of PGⅠ/Ⅱ in the patients with gastric cancer were(31.09±10.24)ng/mL and(9.67±7.23)ng/mL respectively and both lower than those in health people(P0.05).The serum PGⅠ/Ⅱ concentrations in gastric cancer patients without recrudescence or metastasis in postoperative more than three years was(129.43±51.00)ng/mL and(23.83±13.68)ng/mL respectively,which were significantly higher than those in newly diagnosed patients(P0.05).The serum concentration of MG-7Ag in the patients with gastrelcosis or gastric cancer had high dispersion coefficient and had no relativity with that of PGⅠ.The specificity and sensitivity of MG-7Ag for diagnosis of gastric cancer was 81.1% and 56.7% respectively,which of PGⅠ were 91.9% and 76.7% respectively.Conclusion Serum PG detection could provide the evidence for the diagnosis,follow-up and prognosis of gastric cancer,which is better than MG-7Ag detection.
作者 吴小平
出处 《检验医学与临床》 CAS 2012年第19期2415-2416,2418,共3页 Laboratory Medicine and Clinic
关键词 胃蛋白酶原 胃癌 单抗7相关抗原 pepsinogen gastric cancer monoclonal gastric cancer 7 antigen
  • 相关文献

参考文献9

二级参考文献33

  • 1杨力,王平.幽门螺杆菌抗体和血清胃蛋白酶原与慢性胃炎及胃癌的关系[J].河北医药,2004,26(10):773-774. 被引量:13
  • 2吴云林,涂水平.早期胃癌的筛选[J].齐鲁肿瘤杂志,1996,3(1):6-7. 被引量:2
  • 3金妮 沈铭昌.胃蛋白酶原在胃癌及癌前病变组织中的表达[J].中华病理杂志,1991,(2):84-84.
  • 4FurutaT.血清胃蛋白酶原的百分率变化是幽门螺杆菌根除的有用标志[J].国外医学:消化系疾病分册,1998,18(2):111-111.
  • 5Samloff I M. PepsinogenⅠ and Ⅱpurification from gstric mucosa and radioimmunoassay in serum. Gastroenterology. 1982,82:26.
  • 6Westerverid BD, Pals G, Lamers CBH W, et al. Cinical significance of pepsinogen A isozymogens, serum pepsinogen A and Clevels, and serum gstrin levels. Cancer. 1987, 59:952.
  • 7Ichinose M, Miki M, Furihata C, et al. Radioimmunoassay of serumgroup and pepsinogens in normal controls and patients with various disor-ders. Clin Chima Acta. 1982,126:183.
  • 8Smloff IM. Elevated serum pepsinogen and levels differ as risk fac-tors for duodenal ulcer and gstric ulcer. Gastroenterology. 1986, 90:57.
  • 9Matsushima M, Miki K, Ichinose M, et al. Serum pepsinogen value as possible markers for evaluating the possibility of peptic ulcer recurrent under H2-bloker half-dose maintenance therapy. Aspartic proteinases: structure, function, biology and biochemical implications. Takahashi K. Plenum Press. New York. 1995,131.
  • 10文洽先.胃癌手术前后血清胃蛋白酶原含量变化的临床意义[J].南通医学院学报,1999,19(2):172-173. 被引量:4

共引文献277

同被引文献52

引证文献6

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部